Normal mouse and rabbit igg hrb secondary antibodies

Manufactured by Santa Cruz Biotechnology

Sourced in United States

Normal mouse and rabbit IgG-HRB secondary antibodies are used to detect and quantify target proteins in various immunoassays. They bind to the primary antibody, which is specific to the target protein, and the attached horseradish peroxidase (HRP) enzyme allows for colorimetric or chemiluminescent detection.

Automatically generated - may contain errors

Lab products found in correlation

Necrostatin 1, by Selleck Chemicals (2 mentions) Necrosulfonamide, by Selleck Chemicals (2 mentions) Sorafenib bay 43 9006, by Merck Group (2 mentions) Z vad fmk, by Selleck Chemicals (2 mentions) β actin sc 8432, by Santa Cruz Biotechnology (1 mentions) Gapdh, by Bioworld Technology (1 mentions) β actin, by Santa Cruz Biotechnology (1 mentions) β tubulin, by Santa Cruz Biotechnology (1 mentions)

Close spelling variants of this product

Normal rabbit IgG (271 citations) Normal mouse IgG (221 citations) Normal IgG (36 citations) Mouse secondary antibodies (6 citations) IgG mouse (6 citations) Normal rabbit/mouse IgG (3 citations) IgG Rabbit (3 citations) Mouse IgGs (3 citations) Mouse IgG antibodies (2 citations) Rabbit IgGs (2 citations)

2 protocols using normal mouse and rabbit igg hrb secondary antibodies

Dissecting Cell Death Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols

Sorafenib (Bay 43-9006, Sigma-Aldrich), 17-AAG (Tanespimycin, MCE, HSP90α inhibitor), Z-VAD-FMK (Selleck, Caspase Inhibitor), Necrostatin-1 (Selleck, RIPK1 inhibitor), Necrosulfonamide (Selleck, MLKL inhibitor).
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenytetrazoliumbromide) was obtained from Fluka Chemical Corp (Ronkonkoma, NY, USA) and was dissolved in 0.01 M phosphate-buffered saline (PBS). Antibodies against RIPK1(A7414), RIPK3(A5431), MLKL(A5579), HIF-1α(A16873) were purchased from Abclonal Technology (Wuhan, China). Antibodies against, HSP90α(BS6461), were products of Bioworld Technology (USA). Antibodies against AFP (4448) and LAMP2 (49067) were products of Cell Signaling Technology (Beverly, MA, USA). Antibodies against Lamin A (sc-293162), β-Tubulin (sc-166729) and β-Actin (sc-8432) were products of Santa Cruz Biotechnology (USA). Normal mouse and rabbit IgG-HRB secondary antibodies were purchased from Santa Cruz Biotechnology.

Liao Y., Yang Y., Pan D., Ding Y., Zhang H., Ye Y., Li J, & Zhao L. (2021). HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia. Cancers, 13(2), 243.

+ Open protocol

+ Expand

Investigating Cell Death Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols

Sorafenib Bay 43-9006, Sigma-Aldrich), 17-AAG (Tanespimycin, MCE, HSP90 inhibitor), Z-VAD-FMK (Selleck, Caspase Inhibitor), Necrostatin-1 (Selleck, RIPK1 inhibitor) Necrosulfonamide (Selleck, MLKL inhibitor). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenytetrazoliumbromide) was obtained from Fluka Chemical Corp (Ronkonkoma, NY, USA) and was dissolved in 0.01 M phosphate-buffered saline (PBS).
Antibodies against RIPK1, RIPK3, MLKL, were purchased from Abclonal Technology (Wuhan, China). Antibodies against HIF-1α, HSP90α, p-MLKL, and GAPDH were products of Bioworld Technology (USA).
Antibodies against AFP and LAMP2 were products of Cell Signaling Technology (Beverly, MA, USA). Antibodies against Lamin A, β-Tubulin and β-Actin were products of Santa Cruz Biotechnology (USA).
Normal mouse and rabbit IgG-HRB secondary antibodies were purchased from Santa Cruz Biotechnology.

Yan L., Yang Y., Pan D., Ding Y., Zhang H., Ye Y., Li J., & Zhao L.N. (2020). HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition Under Hypoxia.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!